Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Crescita Therapeutics Inc T.CTX

Alternate Symbol(s):  CRRTF

Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial... see more

TSX:CTX - Post Discussion

Crescita Therapeutics Inc > Ghost town here
View:
Post by Stonksonlyup90 on Mar 23, 2022 11:07am

Ghost town here

Company just posted phenomenal Q4 results and not a peep here or on other investor boards that I follow... this name is soooo undervalued. If they can put out another result like Q4 we are headed back to $1.00
Comment by Eldoradosucks on Mar 23, 2022 11:29pm
Let's hope this get higher. It's really undervalued
Comment by lscfa on Mar 24, 2022 12:04am
Co. has lumpy revenues due to 1-time upfront licensing fees so looking at a qtr is unwise. 12 month revenues little changed and profitability is weak.    
Comment by Stonksonlyup90 on Mar 24, 2022 2:10pm
Tell that to the share price... EV at $0.80 is roughly $5.3M.. lumpy or not the TTM EBITDA is $1M (anticipated to grow with the large PO secured this past year).  if we do, say $1M in EBITDA next Q we are trading at EV/EBITDA on a TTM basis of 3x... pretty cheap if you ask me
Comment by DrewJackson on Aug 29, 2022 10:16am
Crescita needs a new CEO, in my opinion.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities